News
As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...
Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...
Serena Williams Reveals Her Weight Loss Journey: After Kids, GLP-1s Were “A Medicine My Body Needed”
In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...
Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...
The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results